InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
T+90 hit rate
38%
T+90 mean return
-7.5%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Ciaffoni Joseph, Chairman & CEO. Officer active across 3 companies, notably COLLEGIUM PHARMACEUTICAL, INC. Cumulatively, 28 disclosures have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €2.4m. History available since 1 June 2021. The latest transaction was disclosed on 12 February 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations28 total
1,266,903 sharesCommon StockSEC:0001443841-26-000007:0
612,549 sharesCommon StockSEC:0001443841-26-000007:1
119,000 shares0Common StockSEC:0001062993-24-003166:0
4,357 shares@ US$21.341.8% of flowCommon StockSEC:0001062993-23-023100:0
27,798 shares@ US$21.3411.9% of flowCommon StockSEC:0001062993-23-022977:0
31,272 shares@ US$22.088714.0% of flowCommon StockSEC:0001062993-23-012809:0
31,271 shares@ US$21.902313.9% of flowCommon StockSEC:0001062993-23-012623:0
117,500 shares0Common StockSEC:0001062993-23-003475:0
110 shares@ US$23.000.1% of flowCommon StockSEC:0001062993-22-024500:0
147 shares@ US$23.000.1% of flowCommon StockSEC:0001062993-22-024500:1
1,804 shares@ US$23.650.9% of flowCommon StockSEC:0001062993-22-024500:2
400 shares@ US$24.190.2% of flowCommon StockSEC:0001062993-22-024500:3
1,134 shares@ US$23.010.5% of flowCommon StockSEC:0001062993-22-024355:0
76,653 shares@ US$15.9025.5% of flowCommon StockSEC:0001062993-22-023357:0
43 shares@ US$15.900.0% of flowCommon StockSEC:0001062993-22-022995:0
65 shares@ US$15.900.0% of flowCommon StockSEC:0001062993-22-022779:0
1,989 shares@ US$15.900.7% of flowCommon StockSEC:0001062993-22-022644:0
1,394 shares@ US$18.160.5% of flowCommon StockSEC:0001062993-22-016068:0
65,083 shares@ US$18.370.073% mcap77.3% of flowCommon StockSEC:0001062993-22-006644:0
125,000 shares0Common StockSEC:0001062993-22-004320:0
1,090 shares@ US$18.680.0012% mcap11.5% of flowCommon StockSEC:0001879789-22-000001
1,090 shares@ US$18.680.0012% mcap1.3% of flowCommon StockSEC:0001879789-22-000001:0
1,386 shares@ US$19.030.5% of flowCommon StockSEC:0001192482-21-000661
1,386 shares@ US$19.030.0015% mcap1.6% of flowCommon StockSEC:0001192482-21-000661:0
1,394 shares@ US$23.990.6% of flowCommon StockSEC:0001192482-21-000623
25 of 28 declarations
About Ciaffoni Joseph
Joseph Ciaffoni is the President and CEO of Collegium Pharmaceutical, Inc. He is responsible for the strategic and operational direction of the company. Ciaffoni plays a key role in implementing new initiatives and optimizing performance. His experience in the pharmaceutical sector is an asset for Collegium.
